Sadahisa Ogasawara, Shinji Itoh, Rie Sugimoto, Yuki Kugiyama, Fumihito Hirai, Hiromitsu Hayashi, Yuichi Honma, Seiichi Mawatari, Ken Shirabe, Toshimasa Koyanagi, Takuya Kuwashiro, Tatsuji Maeshiro, Atsuhi Hiraoka, Norifumi Harimoto, Yasunori Ichiki, Futa Koga, Kengo Fukuzawa, Hamano Tetsutaro, Eiji Oki, Tomoharu Yoshizumi. "Real-world prospective comparison of sorafenib and lenvatinib as first-line therapy for unresectable hepatocellular carcinoma: A multicenter study in Japan (KSCC HAMRET).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.2_suppl.562